Lewy Body Dementia Research in Latin America: A Scoping Review
Authors:
- Carlos Cano‐GutiérrezCCCarlos Cano‐Gutiérrez
- Salomón Salazar‐LondoñoSalomón Salazar‐Londoño
- Felipe Botero‐RodriguezFBFelipe Botero‐Rodriguez
- Salomón Páez‐GarcíaSalomón Páez‐García
- Salomón GiraldoSGSalomón Giraldo
- José Manuel Santacruz‐EscuderoJSJosé Manuel Santacruz‐Escudero
- Dag AarslandDADag Aarsland
- Miguel Germán BordaMBMiguel Germán Borda
- Col‐ DlbCDCol‐ Dlb
Open Access
- 21 April 2025
- journal article
- review article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 12 (8) , 1053-1065
Abstract
Background: Dementia research in Latin America (LA) has primarily focused on Alzheimer's Disease and Frontotemporal Dementia, while Lewy body dementia (LBD) has been largely forgotten.Objective: We aimed to review the available evidence on LBD in LA, offering a comprehensive perspective for understanding the lack of reports and the unique challenges and characteristics of this region.Methods: We carried out a scoping review in databases: PubMed, EMBASE, LILACS, and Web of Science. Original studies that included participants with LBD were analyzed.Results: Of the 1388 studies identified, 70 met the inclusion criteria for this review. Among them, 63 were cross‐sectional studies, three were cohort studies, two followed a case–control methodology, and only two were non‐randomized clinical trials. These studies primarily examined clinical manifestations, risk factors, neuropsychiatric and non‐motor symptoms, as well as cognitive impairment and its assessment in LBD within LA. Regarding geographical distribution, 52 studies were conducted in Brazil, seven in Argentina, the rest in Peru, Mexico, Colombia, Cuba, and Chile.Conclusions: LBD research in LA is underrepresented, with most studies being cross‐sectional, few utilizing a longitudinal design, and only two clinical trials, both of which lack rigorous methodology. Challenges include weak study designs, high heterogeneity, limited trials, and unclear differentiation within the LBD spectrum. Addressing these gaps requires increasing awareness, strengthening research capacity, securing funding, and fostering international collaboration.Keywords
Funding Information
- National Institute for Health and Care Research
- South London and Maudsley NHS Foundation Trust
- Helse Vest
- Nasjonalforeningen for Folkehelsen
This publication has 89 references indexed in Scilit:
- Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico CityAlzheimer's & Dementia, 2024
- Neuropathological correlates of neuropsychiatric symptoms in dementiaAlzheimer's & Dementia, 2022
- Addressing dementia challenges through international networks: Evidence from the Latin American and Caribbean Consortium on Dementia (LAC‐CD)Alzheimer's & Dementia, 2021
- Anosognosia for memory in dementia with Lewy bodies compared with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2021
- Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working groupAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
- Facial tremors in patients with and without parkinsonismNeurological Sciences, 2016
- α‐Synuclein inclusions in the skin of Parkinson's disease and parkinsonismAnnals of Clinical and Translational Neurology, 2014
- Psychopathological features in patients with Parkinson's disease and related caregivers' burdenInternational Journal of Geriatric Psychiatry, 2009
- Defining the Review Question and Developing Criteria for Including Studies2008
- The Unified Parkinson's Disease Rating Scale: Validation study of the mentation, behavior, and mood sectionMovement Disorders, 2007